ConvaTec Regulatory News (CTEC)

ConvaTec Group PLC

Non-Executive Director Resignation

Reading, United Kingdom - Thursday 17 March 2022

ConvaTec Group PLC ("ConvaTec" or "the Company") announces that Dr Regina Benjamin, Non-Executive Director, has decided not to seek re-election at the Company's forthcoming Annual General Meeting ("AGM") and will step down from the Board at the close of the AGM on 12 May 2022. Regina will step down from ConvaTec's Remuneration and Nomination committees on the same date.

Regina has made a valuable contribution to the Board's deliberations since 2017. One of Regina's other NED roles for a private US company has recently expanded following an IPO and this has led to Regina's decision to step down from the Board of ConvaTec.

John McAdam, Chairman of ConvaTec, commented:

"The Board is sorry to lose Regina's valuable contribution to the Board's discussions for nearly 5 years. The Board understands that Regina's other commitments have increased and on behalf of the Board, I wish Regina every success and happiness for the future."

Enquiries:

Analysts and Investors

Kate Postans, Vice President, Investor Relations +44(0)7826 447 807

ir@convatec.com

Media

Buchanan: Chris Lane +44(0)207 466 5000

ConvaTec Group PLC's LEI code is 213800LS272L4FIDOH92

About ConvaTec Group PLCConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com